Business
Press Release Mar 31 2023
Lupin Limited has informed the Exchange regarding a press release dated March 31, 2023, titled "Lupin Receives Approval from U.S. FDA for Tenofovir Alafenamide Tablets".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated March 31, 2023, titled \"Lupin Receives Approval from U.S. FDA for Tenofovir Alafenamide Tablets\". View Attachment","length":335,"tagName":"div"}]